Bedier H, Isnard S, Maedler-Kron C, Routy J-P. Long-term tolerance and efficacy of siltuximab (anti-IL-6) in a young adult with idiopathic multicentric Castleman disease during COVID-19. EJCRIM 2023;10 doi:10.12890/2023_004098.